Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

inVentiv Health Inc.

www.inventivhealth.com

Latest From inVentiv Health Inc.

Appointments: Ionis, ThromboGenics, Zelluna, Therapix, OncoSec, Orion, Storm Therapeutics and ALK

This week's round-up includes new CEOs at Zelluna, Therapix Biosciences and OncoSec Medical, a new COO at Ionis, two C-Suite appointments at ThromboGenics, and a new oncology head at Orion.

Appointments BioPharmaceutical

Biopharma Quarterly Deal-Making Statistics, Q2 2017

Biopharma companies raised $13.4 billion in Q2, mostly through IPOs. Thanks to several billion-dollar deals in Q2, 2017 is shaping up to be a year of CRO consolidations. Big pharma continued divesting assets to smaller biopharma companies.

BioPharmaceutical Deals

BIO Notebook, Day 2: Deal Insights, A Payer Perspective And EMA Rumors

In the spirit of the BIO International Convention's partnering focus, Scrip covered a dealmaker survey and spoke to Bayer about some of its business development priorities on day two of the annual convention. We also report on a payer perspective, post-Brexit EMA rumors and investments in vaccines.

Deals Business Strategies

CRO Sector In Good Health With More Consolidation Coming

The wave of merger and acquisitions that has washed through the contract research organization sector this year is set to continue as the pharmaceutical industry increasingly turns to outsourcing for its clinical needs.

M & A Market Intelligence
See All

Company Information

  • Industry
  • Contract Research, Toxicology Testing-CRO
  • Pharmaceuticals
  • Services
  • Therapeutic Areas
  • Non-Specific
  • Alias(es)
  • Ventiv Health Inc.
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • inVentiv Health Inc.
  • Senior Management
  • Michael Bell, Chmn. & CEO
    Jonathan E Bicknell, CFO
    Kristen Spensieri, Global Head, Corp. Communications & Mktg.
  • Contact Info
  • inVentiv Health Inc.
    Phone: (800) 416-0555
    470 Atlantic Ave.
    Boston, MA 02210
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register